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ABSTRACT
Dermatofibrosarcoma protuberans (DFSP) is an uncommon soft tissue neoplasm of low metastatic potential notable for 
its progressive growth and high rate of local recurrence after surgical excision. Fibrosarcomatous transformation of DFSP 
(FS-DFSP) is a rare variant characterized by higher rates of local recurrence and metastasis. Trauma has been hypothesized 
as a potential risk factor for the development of DFSP, although clear evidence has been lacking. In this study, we report a 
case of FS-DFSP that was found arising from a previously stable scar following a traumatic injury. A 49-year-old male was 
diagnosed with keloid scars following a motor vehicle accident where he sustained trauma. 12 years later, a large tumor 
developed immediately after a second traumatic event to the primary scar. Pathology of the excisional biopsy specimen 
demonstrated FS-DFSP with focal areas consistent with keloid and hypertrophic scar. This observation demonstrates the 
development of DFSP from underlying scar following a clear history of trauma. Furthermore, it suggests trauma as a 
possible trigger for the fibrosarcomatous transformation of DFSP. 
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CASE REPORT
A 49-year-old African American male presents with 
a large mass on the left shoulder that has been rapidly 
enlarging for the past 2 months. The mass grew over a 
presumed keloid scar, which developed approximately 
1 month following a motor vehicle accident 12 years 
prior. During the accident, he suffered a contusion to 
the left shoulder that first bruised and subsequently 
formed a golf ball-sized mass. There was no breakage 
of skin on the left shoulder. He sought medical 
attention for the skin lesion at that time and was 
diagnosed with keloid, which was readily accepted as 
he had past medical history and similar family history. 
No treatment for the lesion was performed at that 
time. Since then, the lesion had been stable without 
any change in shape, color, or size until 1.5 years prior 
to evaluation, when he suffered a minor trauma to 
the lesion during a work-related injury that did not 
break the skin barrier. Following this event, he noticed 
that the lesion slowly increased in size under the skin 
without apparent cutaneous changes in appearance. 
Two months before the clinical encounter, he noticed 
a new rapidly growing nodule on the surface of the 
initial mass. He noticed no changes in symptomatology 
other than left shoulder pain and limited range of 
motion of the neck that became more prominent as 
the mass increased in size.
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On examination, there were three discrete 
protuberant tumor nodules, gray-white, involving 
the skin and subcutis. The largest nodule measured 
16 × 15 × 7 cm and the smallest nodule measured 
7 × 6 × 3 cm (Figure 1).
The tumor was ulcerated and necrotic without 
apparent attachment to underlying structures. Anterior 
cervical, posterior cervical, supraclavicular, and axillary 
lymph nodes were not palpable bilaterally, and there 
were no other masses observed. CT of thorax suggested 
the masses were superficial with no attachment to 
underlying bone or great vessels, and there was 
no evidence of metastatic disease or adenopathy. 
A wide excisional biopsy of the lesion was performed. 
The histological examination revealed a fascicular 
architectural pattern composed of plump spindle cells 
with high nuclear grade atypia and numerous mitoses 
leading to the diagnosis of high-grade fibrosarcoma 
arising from DFSP (Figure 2A). The spindle cells diffusely 
express CD34 (Figure 2B).
There were areas showing a transition from scar 
to DFSP (Figure 3), and focal areas were consistent 
with keloid.
There was also invasion of the lesion into the 
underlying skeletal muscle as well as focal areas 
at the deep surgical margin. The post-op course 
was uneventful. Due to the location and extent 
of the invasion, further excision was not feasible. 
A multidisciplinary approach including radiation 
oncology will be pursued for further treatment. 
The current plan involves the placement of a skin graft 
over the incision site followed by radiation treatment to 
target the remaining lesion. The patient will continue 
to be observed for recurrence of the tumor to allow 
for early resection.
DISCUSSION
Dermatofibrosarcoma protuberans (DFSP) is a 
relatively rare soft tissue sarcoma with an estimated 
overall annual incidence of 4.2 cases per one million 
persons per year. Black people are affected at almost 
Figure 1. Resection of the lesion was performed with 
wide surgical margins from the left mid-clavicular 
region. The largest mass measured 16 × 15 × 7 cm and 
the smallest mass measured 7 × 6 × 3 cm.
Figure 2. Photomicrograph of resected mass. A – demonstrates fibrosarcomatous differentiation of DFSP with 
cellular atypia with abundant mitotic activity (H&E, 40X); B – Immunohistochemistry staining for CD34 marker is 
diffusely expressed in the spindle cells and highlights the fascicular pattern of this tumor (20x).
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2 times the rate of whites, and incidence among 
women is 1.14 times higher than among men.1 
Trauma has been hypothesized as a predisposing 
factor for DFSP, with reported cases of tumors arising 
from vaccination sites, burn scars, and surgical scars.2 
These studies3-6 document roughly 10% of patients 
providing a history of antecedent traumatic insult; 
however, mechanistic basis and clear causative 
relationship have not been identified.7 DFSP accounts 
for less than 0.1% of all malignant neoplasms, but it 
is the most common type of skin sarcoma. The lesion 
most commonly appears on the trunk, proximal 
extremities, and the head and neck. Initially, the tumor 
may appear as a sclerotic plaque-like mass with bluish 
skin discoloration which can be misinterpreted as a 
keloid. The tumor may show an initial slow growth 
phase for several years characterized by lateral spread 
before reaching a rapid growth phase with vertical 
infiltration and fixation to deep structures. As the mass 
enlarges, the overlying skin may ulcerate and bleed.8 
Fibrosarcomatous transformation in DFSP represents 
tumor progression marked by a more aggressive clinical 
behavior with higher rates of local recurrence and 
metastasis.9,10 Histopathology of fibrosarcomatous foci 
demonstrates higher cellularity and fascicular pattern 
of growth rather than the storiform pattern normally 
seen in DFSP.11
Molecular studies have demonstrated that 
most cases of DFSP can be differentiated from other 
dermatofibromas by the presence of a t(17;22)(q22;q13) 
translocation forming a PDGFB/COL1A1 fusion gene 
containing a protein of a collagen 1 subunit and 
a platelet derived growth factor (PDGF) subunit. 
The translocation has been demonstrated to be present 
in up to 90% of cases and is a very useful marker for 
differential diagnosis.12 Additionally, DFSPs with higher 
proportions of histologically fibrosarcomatous zones 
have been demonstrated to have a higher proportion 
of the translocation. Research investigating the 
significance of the translocation is still being conducted; 
nevertheless, the detection of the fusion gene using 
fluorescence in-situ hybridization (FISH) currently serves 
as an additional modality of DFSP diagnosis.
Surgical resection remains the treatment of 
choice, which can be achieved with standard wide local 
excision with negative margins or Mohs micrographic 
surgery.7,13 Currently, a 2-3 cm margin is recommended 
for resection, and radiotherapy has been postulated as 
an option for adjuvant therapy, especially in the setting 
of positive surgical margins when further resection is 
not feasible.14,15 Chemotherapy with imatinib mesylate 
has been used with demonstrable disease regression 
in DFSP; however, its efficacy and durability for the 
treatment of FS-DFSP is limited, with most cases 
showing initial response followed by relapse.16
Although DFSP rarely metastasizes, FS-DFSP 
has a reported metastatic rate of between 14% and 
18%.10,17 Both disease processes can be locally invasive 
and has a high rate of local recurrence after surgical 
excision. According to the review of 913 DFSP cases 
by Rutgers et al.,18 recurrence after adequate wide 
excision was 13% compared to the overall recurrence 
rate of about 50%. Given the tendency for rapid 
growth, local invasion, recurrence, and cosmetic 
disfigurement, locally malignant processes such as 
DFSP should be suspected when patients present with 
perceived changes in previously stable lesions, even 
when prior history of trauma clearly predated the skin 
lesion. Furthermore, because our case demonstrates 
that DFSP may arise from an underlying scar, clinicians 
should maintain clinical suspicion of changing lesions 
even in the setting of biopsy proven benign lesions.
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